Expanded Access Program for Treatment With Ecopipam for Tourette's Disorder

NCT07093541 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Tourettes Disorder
Tourette Disorder

Interventions

DRUG: ecopipam HCl ~2mg/kg/day

Sponsor

Emalex Biosciences Inc.